{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T18:17:02Z","timestamp":1782325022899,"version":"3.54.5"},"reference-count":24,"publisher":"Japanese Society of Internal Medicine","issue":"17","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2018,9,1]]},"DOI":"10.2169\/internalmedicine.0438-17","type":"journal-article","created":{"date-parts":[[2018,4,26]],"date-time":"2018-04-26T18:24:32Z","timestamp":1524767072000},"page":"2459-2466","source":"Crossref","is-referenced-by-count":13,"title":["Effect of Eplerenone on the Glomerular Filtration Rate (GFR) in Primary Aldosteronism: Sequential Changes in the GFR During Preoperative Eplerenone Treatment to Subsequent Adrenalectomy"],"prefix":"10.2169","volume":"57","author":[{"given":"Yujiro","family":"Nakano","sequence":"first","affiliation":[{"name":"Department of Molecular Endocrinology and Metabolism, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takanobu","family":"Yoshimoto","sequence":"additional","affiliation":[{"name":"Department of Molecular Endocrinology and Metabolism, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuya","family":"Fukuda","sequence":"additional","affiliation":[{"name":"Department of Molecular Endocrinology and Metabolism, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masanori","family":"Murakami","sequence":"additional","affiliation":[{"name":"Department of Molecular Endocrinology and Metabolism, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryotaro","family":"Bouchi","sequence":"additional","affiliation":[{"name":"Department of Molecular Endocrinology and Metabolism, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isao","family":"Minami","sequence":"additional","affiliation":[{"name":"Department of Molecular Endocrinology and Metabolism, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koshi","family":"Hashimoto","sequence":"additional","affiliation":[{"name":"Department of Molecular Endocrinology and Metabolism, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Japan"},{"name":"Department of Preemptive Medicine and Metabolism, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhisa","family":"Fujii","sequence":"additional","affiliation":[{"name":"Department of Urology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazunori","family":"Kihara","sequence":"additional","affiliation":[{"name":"Department of Urology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihiro","family":"Ogawa","sequence":"additional","affiliation":[{"name":"Department of Molecular Endocrinology and Metabolism, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Funder JW, Carey RM, Mantero F, et al. The management of primary aldosteronism: case detection, diagnosis, and treatment: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 101: 1889-1916, 2016.","DOI":"10.1210\/jc.2015-4061"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Rossi GP, Bernini G, Caliumi C, et al. A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients. J Am Coll Cardiol 48: 2293-2300, 2006.","DOI":"10.1016\/j.jacc.2006.07.059"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Milliez P, Girerd X, Plouin PF, et al. Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism. J Am Coll Cardiol 45: 1243-1248, 2005.","DOI":"10.1016\/j.jacc.2005.01.015"},{"key":"4","doi-asserted-by":"publisher","unstructured":"4. Rossi GP, Bernini G, Desideri G, et al. Renal damage in primary aldosteronism: results of PAPY Study. Hypertension 48: 232-238, 2006.","DOI":"10.1161\/01.HYP.0000230444.01215.6a"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Ribstein J, Cailar GD, Fesler P, Mimran A. Relative glomerular hyperfiltration in primary aldosteronism. Clin J Am Soc Nephrol 16: 1320-1325, 2005.","DOI":"10.1681\/ASN.2004100878"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Sechi LA, Fabio AD, Bazzocchi M, et al. Intrarenal hemodynamics in primary aldosteronism before and after treatment. J Clin Endocrinol Metab 94: 1191-1197, 2009.","DOI":"10.1210\/jc.2008-2245"},{"key":"7","doi-asserted-by":"publisher","unstructured":"7. Sechi LA, Novello M, Lapenna R, et al. Long-term renal outcomes in patients with primary aldosteronism. JAMA 295: 2638-2645, 2006.","DOI":"10.1001\/jama.295.22.2638"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Rossi GP, Sechi LA, Giacchetti G, et al. Primary aldosteronism: cardiovascular, renal and metabolic implications. Trends Endocrinol Metab 19: 88-90, 2008.","DOI":"10.1016\/j.tem.2008.01.006"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Catena C, Colussi G, Nadalini E, et al. Relationships of plasma renin levels with renal function in patients with primary aldosteronism. Clin J Am Soc Nephrol 2: 722-731, 2007.","DOI":"10.2215\/CJN.00050107"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Reincke M, Rump LC, Quinkler M, et al. Risk factors associated with a low glomerular filtration rate in primary aldosteronism. J Clin Endocrinol Metab 94: 869-875, 2009.","DOI":"10.1210\/jc.2008-1851"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Amar L, Lorthioir A, Azizi M, Plouin PF. Progress in primary aldosteronism. Mineralocorticoid antagonist treatment for aldosterone-producing adenoma. Eur J Endocrinol 172: R125-R129, 2015.","DOI":"10.1530\/EJE-14-0585"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Fourkiotis V, Vonend O, Diederich S, et al. Effectiveness of eplerenone or spironolactone treatment in preserving renal function in primary aldosteronism. Eur J Endocrinol 168: 75-81, 2012.","DOI":"10.1530\/EJE-12-0631"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Iwakura Y, Morimoto R, Kudo M, et al. Predictors of decreasing glomerular filtration rate and prevalence of chronic kidney disease after treatment of primary aldosteronism: renal outcome of 213 cases. J Clin Endocrinol Metab 99: 1593-1598, 2014.","DOI":"10.1210\/jc.2013-2180"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Garthwaite SM, McMahon EG. The evolution of aldosterone antagonists. Mol Cell Endocrinol 217: 27-31, 2004.","DOI":"10.1016\/j.mce.2003.10.005"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Ogihara T, Kikuchi K, Matsuoka H, et al. The Japanese Society of Hypertension guidelines for the management of hypertension (JSH 2009). Hypertens Res 32: 3-107, 2009.","DOI":"10.1038\/hr.2009.34"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Nishikawa T, Omura M, Satoh F, et al. Guidelines for the diagnosis and treatment of primary aldosteronism -The Japan Endocrine Society 2009- advance publication. Endocr J 58: 711-721, 2011.","DOI":"10.1507\/endocrj.EJ11-0133"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Seino Y, Nakajo K, Tajima N, et al. Report of the committee on the classification and diagnostic criteria of diabetes mellitus. Diabetol Int 1: 2-20, 2010.","DOI":"10.1007\/s13340-010-0006-7"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Matsuo S, Imai E, Horio M, et al. Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis 53: 982-992, 2009.","DOI":"10.1053\/j.ajkd.2008.12.034"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Wu VC, Kuo CC, Wang SM, et al. Primary aldosteronism: changes in cystatin C-based kidney filtration, proteinuria, and renal duplex indices with treatment. J Hypertens 29: 1778-1786, 2011.","DOI":"10.1097\/HJH.0b013e3283495cbb"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Gaddam K, Corros C, Pimenta E, et al. Rapid reversal of left ventricular hypertrophy and intracardiac volume overload in patients with resistant hypertension and hyperaldosteronism - a prospective clinical study. Hypertens 55: 1137-1142, 2010.","DOI":"10.1161\/HYPERTENSIONAHA.109.141531"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Utsumi T, Kawamura K, Imamoto T, et al. Preoperative masked renal damage in Japanese patients with primary aldosteronism: Identification of predictors for chronic kidney disease manifested after adrenalectomy. Int J Urol 20: 685-691, 2013.","DOI":"10.1111\/iju.12029"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Tanase-Nakao K, Naruse M, Nanba K, et al. Chronic kidney disease score for predicting postoperative masked renal insufficiency in patients with primary aldosteronism. Clin Endocrinol 81: 665-670, 2014.","DOI":"10.1111\/cen.12497"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Catena C, Colussi GL, Nadalini E, et al. Cardiovascular outcomes in patients with primary aldosteronism after treatment. Arch Intern Med 168: 80-85, 2008.","DOI":"10.1001\/archinternmed.2007.33"},{"key":"24","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1161\/HYPERTENSIONAHA.107.095448","volume":"50","author":"C Catena","year":"2007","unstructured":"24. Catena C, Colussi GL, Lapenna R, et al. Long-term cardiac effects of adrenalectomy or mineralocorticoid antagonists in patients with primary aldosteronism. Hypertension 50: 911-918, 2007.","journal-title":"Hypertension","ISSN":"https:\/\/id.crossref.org\/issn\/0194-911X","issn-type":"print"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/57\/17\/57_0438-17\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,17]],"date-time":"2019-10-17T00:05:37Z","timestamp":1571270737000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/57\/17\/57_0438-17\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,1]]},"references-count":24,"journal-issue":{"issue":"17","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.0438-17","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,1]]}}}